INOVIO Pharmaceuticals

INOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory Papillomatosis

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a cutting-edge DNA medicine designed to treat recurrent respiratory papillomatosis (RRP). …

INOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory Papillomatosis Read More


Unisys Corporation

Unisys Unveils Advanced Route Optimization Technology to Address Freight Industry Challenges

BLUE BELL, PA — Unisys (NYSE: UIS) has launched a groundbreaking multi-modal route optimization (MMRO) module, aimed at revolutionizing logistics management for freight forwarders and third-party logistics companies. Announced at …

Unisys Unveils Advanced Route Optimization Technology to Address Freight Industry Challenges Read More